Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juli 2018

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #102

    Just a moment...

    favicon

    (www.onclive.com)

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #103

      "I
      n addition to the 6 patients who achieved complete responses with daratumumab, 3 patients had very good partial responses, and 7 had partial responses. Only 2 patients did not achieve an objective response to treatment with daratumumab, Kaufman reported"

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #104

        "Response, including complete response, occurred as early as 1 month (or sooner) after the start of treatment. As an example of the activity observed in the study, Kaufman described a patient who had received 6 prior lines of therapy, including autologous stem-cell transplantation, and achieved a complete response within the first month after starting daratumumab infusions".

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #105

          Studie: https://clinicaltrials.gov/ct2/show/NCT02841033

          1 Reply Last reply
          0
          • P Offline
            P Offline
            Parasitism
            wrote on sidst redigeret af
            #106

            Umiddelbart er der 4.500 nye patienter om året i USA med sygdommen. http://amyloidosis.org/facts/al/

            1 Reply Last reply
            0
            • P Offline
              P Offline
              Parasitism
              wrote on sidst redigeret af
              #107

              "
              In the United States, AL amyloidosis is the most common type, with approximately 4,500 new cases diagnosed every year. It usually affects people from ages 50-80, although there are a few cases of people being diagnosed as early as their late 20s. About two-thirds of the patients are male."

              1 Reply Last reply
              0
              • StockBullS Offline
                StockBullS Offline
                StockBull
                wrote on sidst redigeret af
                #108

                Hvis dara kan helbrede 6 ud af 18 og 10 faar det bedre saa er det da fantastisk hvis det er samme forhold for de 4500 der faar sygdommen hvert aar og saa burde kursen da rykke mellem 50 og 100 kr

                1 Reply Last reply
                0
                • M Offline
                  M Offline
                  Mcjean
                  wrote on sidst redigeret af
                  #109

                  Kan det gøre det? Hvad er prisen på behandling og hvor mange får det WW?

                  1 Reply Last reply
                  0
                  • M Offline
                    M Offline
                    Mcjean
                    wrote on sidst redigeret af
                    #110

                    Hvis vi antager 20.000 WW til 1,5mill.kr, så bliver det 30mia kr. eller 4.5bn$, hvoraf 60% vel er maintenance, som så skal have behandling videre med Dara, så når vi vel op på cirka 6bn$, altså 6-dobbelt BB og royalties på ca. 1bn$, noget jeg regner forkert?

                    1 Reply Last reply
                    0
                    • M Offline
                      M Offline
                      Mcjean
                      wrote on sidst redigeret af
                      #111

                      Jeg får nærmere 400-600kr. til kursen, men nu er jeg også rationel anlagt:-D

                      1 Reply Last reply
                      0
                      • M Offline
                        M Offline
                        Mcjean
                        wrote on sidst redigeret af
                        #112

                        Beholder kursmål 2000 indtil videre

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          gentogen
                          wrote on sidst redigeret af
                          #113

                          Altid godt med den slags konservative estimater

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            JKY_VH
                            wrote on sidst redigeret af
                            #114

                            Præcis, lad os nu bevare begge ben på jorden og afvente aktiemånedsbrevets syn på sagen:-)

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #115

                              En eventuel udmelding omkring Orphan designation skal vel komme fra Janssen?

                              1 Reply Last reply
                              0
                              • D Offline
                                D Offline
                                Doc4
                                wrote on sidst redigeret af
                                #116

                                Our retrospective
                                series of 20 consecutive relapsed AL patients treated with
                                DARA monotherapy confirms its efficacy and tolerability in
                                previously treated AL. It is apparent that the single agent activity
                                of DARA in relapsed AL exceeds that seen in relapsed myeloma
                                https://sci-hub.mu/10.1111/bjh.15455

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  Parasitism
                                  wrote on sidst redigeret af
                                  #117

                                  "Based on our initial experience and that of others, monoclonal antibody therapy targeting CD38 seems likely to herald a promising era in AL amyloidosis therapy."

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    Parasitism
                                    wrote on sidst redigeret af
                                    #118

                                    tak for link doc! 🙂

                                    1 Reply Last reply
                                    0
                                    • StockBullS Offline
                                      StockBullS Offline
                                      StockBull
                                      wrote on sidst redigeret af
                                      #119

                                      @Mcjean. Jo med 20.000 kommer jeg ogsaa ca. 400 kurspoint. Men i og med kursen ikke rykker kunne det tyde paa der er noget vi har overset.

                                      1 Reply Last reply
                                      0
                                      • StockBullS Offline
                                        StockBullS Offline
                                        StockBull
                                        wrote on sidst redigeret af
                                        #120

                                        Formoder der kommer TIL at gaa mange aar inder evt. Medicin er godkendt til brug paa sygehusene m.m

                                        1 Reply Last reply
                                        0
                                        • StockBullS Offline
                                          StockBullS Offline
                                          StockBull
                                          wrote on sidst redigeret af
                                          #121

                                          For godt nok er vi kloge med at markedet ikke kan se potentialet kunne tyde paa vi har misset et eller andet for en gangs skyld

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger